This product is for research use only and is not for human consumption or therapeutic use.
CAS Number:
1835667-12-3
Purity:
99.93
Molecular Formula:
C27H30N6O3
Molecular Weight:
486.57
Alternative Names:
BPI-7711
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Rezivertinib (BPI-7711) is an orally active, highly selective and irreversible third-generation EGFR tyrosine kinase inhibitor (TKI). Rezivertinib exhibits high potency against the common activation EGFR and the resistance T790M mutations. Rezivertinib has excellent central nervous system (CNS) penetration and has antitumor activity[1][2].
Storage Temperature:
-20°C, 3 years; 4°C, 2 years (Powder)